Riboflavin for Health & Longevity - Quick Reference Sheet

Riboflavin for Health & Longevity

Created on 10/08/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Sonnet 5.5 – Audit

Riboflavin (vitamin B2) is a vitamin, also sold as a supplement, that cells use to make energy and recycle antioxidants. For adults getting enough from food, evidence for added benefit is limited and uneven. The strongest human data concern migraine prevention at amounts far above dietary needs; a blood pressure effect in carriers of one gene variant rests mainly on a single research group. Documented risks are minor. (Full Review)

Protocol

Migraine protocol (adults)
400 mg daily
Riboflavin for three months
Genotype-targeted blood pressure protocol
1.6 mg daily
For 16 weeks in adults with MTHFR 677TT
Status maintenance
1.3 mg men, 1.1 mg women
Recommended Dietary Allowance; 1.6 or 25 mg corrected low status in older adults
Time to effect
Migraine benefit
Third month
Benefit was most pronounced in the third month
Riboflavin status
Within 12 weeks
Status improved within 12 weeks of 1.6 mg
Biochemical depletion
Within days
Biochemical signs of depletion arise within days of deprivation

Benefits

Contraindications
  • Known hypersensitivity (allergy) to riboflavin or any ingredient in the formulation
Key Interactions
  • Probenecid (gout drug): monitor
  • Phenothiazines and tricyclic antidepressants (antipsychotic and antidepressant classes; chlorpromazine, amitriptyline, imipramine): caution
  • Anthracyclines (chemotherapy class; doxorubicin): caution (theoretical)
  • Barbiturate anticonvulsants (seizure-prevention class; phenobarbital): monitor (theoretical)
  • Oral contraceptives (ethinylestradiol combinations): monitor
  • Antihypertensive drugs (amlodipine, lisinopril, hydrochlorothiazide): monitor
  • Aminoglycosides, erythromycin and bleomycin (streptomycin, kanamycin, erythromycin): caution (theoretical)
  • Propantheline (anticholinergic, a drug that slows gut movement): minor
  • Ticagrelor (antiplatelet drug): minor
  • Boric acid–containing antiseptics and insecticides: caution
  • Aluminum and magnesium hydroxide antacids: minor
  • Urine color tests, fluorometric catecholamine and urobilinogen assays: monitor
  • Folic acid: monitor
  • Niacin (nicotinic acid, nicotinamide): caution
  • Boron supplements (boric acid, sodium borate): caution (theoretical)
  • Alcohol: monitor
  • Strenuous exercise: monitor

Risk & Side Effects

  • High:
  • Medium:
  • Low: Mild Gastrointestinal Upset and Frequent Urination at High Doses; Bright Yellow Urine; Posterior Subcapsular Cataract With Riboflavin Plus Niacin
  • Speculative: Photosensitization of Lens Proteins; Support of Cancer-Cell Growth in Cell Models; DNA Strand Breaks With Chromium VI in Cell Culture; High-Dose Use in Pregnancy and Lactation

Monitoring

Marker Target Why
EGRAC 1.26 or lower (optimal category) Marker the intervention is expected to change: riboflavin status
Blood pressure Below 140/90 mmHg (trial goal) Marker the intervention may change in the 677TT genotype, and safety check alongside antihypertensive drugs
Plasma homocysteine 5 to 15 µmol/L (standard reference range) Marker the intervention may change in the 677TT genotype

Cadence: Baseline (EGRAC, blood pressure; fasting homocysteine for 677TT or hypertension); repeat EGRAC and blood pressure at 12 to 16 weeks, then every 6 to 12 months; migraine diary monthly through the first three months.

Qualitative Assessment

  • Migraine attacks, headache days and severity (diary)
  • Energy levels and fatigue
  • Sleep quality and perceived stress
  • Lip, mouth-corner and tongue condition (deficiency signs)
  • Urine color (bright yellow is expected with higher doses)